Global Autoimmune Disease Therapeutics Market Outlook to 2025

DUBLIN, March 24, 2022 /PRNewswire/ — The report “Global Autoimmune Disease Therapeutics Market: Analysis by Drug Class by Indication by Region Size and Trends with Covid-19 Impact and Forecast to 2025” has been added to from ResearchAndMarkets.com offer.

The report provides an in-depth analysis of the global autoimmune disease therapies market by value, by drug class, by indication and by region.

The report provides regional analysis of the Autoimmune Disease Therapeutics Market including the following regions: North America, Europe, Asia Pacific, Middle East & Africaand Latin America. The report also provides a detailed analysis of the impact of COVID-19 on the autoimmune disease therapies market.

The report also assesses key market opportunities and outlines the factors that are and will be driving the growth of the industry. Global Autoimmune Disease Therapeutics Market growth has also been forecast to 2025, considering previous growth patterns, growth drivers and current and future trends.

The global autoimmune disease therapies market is fragmented with numerous major market players operating across the globe. Key players of Autoimmune Disease Therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson and Abbott Laboratories are also profiled with their respective financial information and business strategies.

An autoimmune disease is a condition in which the body’s immune system mistakenly attacks and destroys healthy cells and tissues in the body. In other words, an autoimmune disease occurs when the immune system fails to distinguish between the body’s own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapy is a form of treatment aimed at calming the overactive immune response, limiting tissue damage, and reducing pain and inflammation. Treatment can also help relieve symptoms such as pain, swelling, and rashes.

There are many treatment alternatives available, but no one option has a perfect safety profile. In fact, while some treatments have been effective in treating some autoimmune diseases, no treatment is effective for all autoimmune diseases.

The autoimmune disease therapies market can be segmented based on drug class (immunosuppressants, anti-inflammatories, interferons, NSAIDs, antihyperglycemics and others); indication (rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, type 1 diabetes, psoriasis and others); and distribution channel (hospitals and clinics, pharmacies, pharmacies, online stores and others).

The global autoimmune disease therapeutics market has grown significantly over the past few years and projections indicate that the market will increase over the next few years. The autoimmune disease therapies market is expected to increase due to rapid urbanization, escalating healthcare expenditures, growing prevalence of autoimmune diseases, favorable government initiatives, and more. pulmonary fibrosis), etc.

Main topics covered:

1. Summary

2. Presentation

3. Global Market Analysis
3.1 Global Autoimmune Disease Therapies Market: An Analysis
3.1.1 Global Autoimmune Disease Therapies Market by Value
3.1.2 Global Autoimmune Disease Therapies Market by Drug Class (Anti-Inflammatories, Interferons, NSAIDs, Antihyperglycemics and Others)
3.1.3 Global Autoimmune Disease Therapeutics Market by Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes and Other Indications)
3.1.4 Global Autoimmune Disease Therapy Market by Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America)
3.2 Global Autoimmune Disease Therapies Market: Drug Class Analysis
3.2.1 Global Autoimmune Disease Anti-Inflammatory Therapies Market by Value
3.2.2 Global Interferon Therapeutics for Autoimmune Diseases Market by Value
3.2.3 Global NSAID Autoimmune Disease Therapeutics Market by Value
3.2.4 Global Antihyperglycemic Autoimmune Disease Therapies Market by Value
3.2.5 Global Other Autoimmune Disease Therapies Market by Value
3.3 Global Autoimmune Disease Therapies Market: Indications Analysis
3.3.1 Global Rheumatoid Arthritis Therapy Market by Value
3.3.2 Global Type 1 Diabetes Therapy Market by Value
3.3.3 Global Multiple Sclerosis Therapeutics Market by Value
3.3.4 Global Inflammatory Bowel Disease Therapeutics Market by Value
3.3.5 Global Other Therapeutic Indications Market by Value

4. Regional Market Analysis
4.1 North America Autoimmune Disease Therapies Market: An Analysis
4.1.1 North America Autoimmune Disease Therapeutics Market by Value
4.2 Europe Autoimmune Disease Therapy Market: An Analysis
4.2.1 Europe Autoimmune Disease Therapeutics Market by Value
4.3 Asia Pacific Autoimmune Disease Therapy Market: An Analysis
4.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Value
4.4 Middle East & Africa Autoimmune Disease Therapeutics Market: An Analysis
4.4.1 Middle East & Africa Autoimmune Disease Therapeutics Market by Value
4.5 Latin America Autoimmune Disease Therapy Market: An Analysis
4.5.1 Latin America Autoimmune Disease Therapeutics Market by Value

5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on the health sector
5.1.2 Impact of COVID-19 on autoimmune disease therapy

6. Market dynamics
6.1 Engine of growth
6.1.1 Rapid urbanization
6.1.2 Increase in health expenditure
6.1.3 Growing prevalence of autoimmune diseases
6.1.4 Supportive government initiatives
6.2 Challenges
6.2.1 High cost involved
6.2.2 Lack of approved treatment for IPF (idiopathic pulmonary fibrosis)
6.3 Market trends
6.3.1 Innovations in the treatment of autoimmune diseases
6.3.2 Growing Adoption of JAK Inhibitors for the Treatment of Autoimmune Diseases
6.3.3 Educate patients about autoimmune diseases and therapeutic treatments

7. Competitive landscape
7.1 Global Autoimmune Disease Therapy Market Players: A Financial Comparison
7.2 Global Autoimmune Disease Therapy Market Players by Drug Development for IMIDs Targeting JAK

8. Company Profiles
8.1 Roche Holding AG
8.1.1 Overview of activities
8.1.2 Financial overview
8.1.3 Business Strategy
8.2 Pfizer Inc.
8.2.1 Overview of activities
8.2.2 Financial overview
8.2.3 Business Strategy
8.3 Johnson & Johnson
8.3.1 Company Overview
8.3.2 Financial overview
8.3.3 Business Strategy
8.4 Abbott Laboratories
8.4.1 Business overview
8.4.2 Financial overview
8.4.3 Business Strategy

For more information about this report, visit https://www.researchandmarkets.com/r/219uo4

Media Contact:

Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Comments are closed.